A Retrospective Review to Determine If Children with Sickle Cell Disease Receive Hydroxyurea Monitoring

INTRODUCTION: Sickle cell disease guidelines recommend that patients on hydroxyurea receive monitoring at least every 2–3 months, but it is unknown if this occurs in clinical practice. This study aimed to determine if patients with sickle cell disease at Nationwide Children’s Hospital had at least 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Creary, Susan E., O’Brien, Sarah H., Stanek, Joseph, Hankins, Jane S., Garee, Amy, Ball, Kyle R., Andrews, Tina M., Chisolm, Deena J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Individual QI Projects from Single Institutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793862/
https://www.ncbi.nlm.nih.gov/pubmed/29399659
http://dx.doi.org/10.1097/pq9.0000000000000024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793862/
https://www.ncbi.nlm.nih.gov/pubmed/29399659
http://dx.doi.org/10.1097/pq9.0000000000000024

Ejemplares similares